The study investigated the effects of the herbal medication L. on breast cancer cells. Results showed that L. significantly reduced cell proliferation, induced cell death, and suppressed migration and colony formation. The findings suggest that L. may be a potential treatment for breast cancer, but further research is needed.
The study found that a herbal melanin derived from Nigella sativa upregulated the TLR4 receptor, increased COX-2 expression, and promoted the secretion of PGE2 and IL-6 in AGS cells. This suggests that the melanin may have gastroprotective effects and potential benefits for gastric prevention and treatment.
Lycopodium Clavatum (LC), an herb, was found to have cytotoxic and apoptotic effects on MCF-7 human breast cancer cells, indicating its potential as an anticancer agent. LC activates apoptosis-related proteins and shows promise as a natural compound for breast cancer treatment.
Six new compounds called euchronin A-F and nine known compounds were discovered in Arnebia euchroma. Compounds 2 and 4 showed strong anti-proliferative activity against HaCaT cells, reducing cell viability to 38.83% and 68.44% at 25 μM concentration.
Correction: Leaf polysaccharides reverse tumor-associated macrophage phenotype targeting TLR4, promote T-cell infiltration, and exhibit anti-lung cancer effects. Important for understanding potential treatments and immunotherapies for lung cancer.
Mexican plants CA and PR show promise in fighting colon cancer cells, with CA being particularly effective in reducing metabolic activity and inducing apoptosis. Further research is required, but these plants hold potential as sources of polyphenols for anticancer treatments.